. 2008 Sep;105(37):2472-3.

[Complicated priorities regarding antithrombotic treatment of atrial fibrillation. Difficult to understand priority list in the national guidelines--new studies can make them clearer]

[Article in Swedish]

Affiliations

[Article in Swedish]

Thomas Mooe. Lakartidningen. 2008 Sep.

. 2008 Sep;105(37):2472-3.

No abstract available

Similar articles

[Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].
Själander A, Wallentin L, Rosenqvist M, Svensson P. Själander A, et al. Lakartidningen. 2008 Sep 10-16;105(37):2478-80. Lakartidningen. 2008. PMID: 19006862 Swedish. No abstract available.
Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
Cairns JA, Connolly S, McMurtry S, Stephenson M, Talajic M; CCS Atrial Fibrillation Guidelines Committee. Cairns JA, et al. Can J Cardiol. 2011 Jan-Feb;27(1):74-90. doi: 10.1016/j.cjca.2010.11.007. Can J Cardiol. 2011. PMID: 21329865
[Guidelines for antithrombotic therapy in atrial fibrillation: what the Italian Hemostasis and Thrombosis Society thinks].
Prisco D. Prisco D. Haematologica. 2001 Sep;86(9 Suppl):12-3. Haematologica. 2001. PMID: 11759618 Italian. No abstract available.
Antithrombotic treatment in atrial fibrillation.
Lip GY, Boos CJ. Lip GY, et al. Postgrad Med J. 2008 May;84(991):252-8. doi: 10.1136/hrt.2005.066944. Postgrad Med J. 2008. PMID: 18508982 Review.
Pro: 'Antithrombotic therapy with warfarin, aspirin and clopidogrel is the recommended regime in anticoagulated patients who present with an acute coronary syndrome and/or undergo percutaneous coronary interventions'.
Rubboli A, Halperin JL. Rubboli A, et al. Thromb Haemost. 2008 Nov;100(5):752-3. Thromb Haemost. 2008. PMID: 18989515 No abstract available.